Verition Fund Management »

Anavex Life Sciences shares owned by Verition Fund Management

Quarter-by-quarter ownership of Anavex Life Sciences (AVXL) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Anavex Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Anavex Life Sciences held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Anavex Life Sciences by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $613k 69k 8.90
2025-06-30 $303k 33k 9.22
2025-03-31 $633k 74k 8.58
2024-12-31 $394k 37k 10.74
2016-03-31 $81k 17k 4.92

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Eli Lilly & Co. (LLY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Warner Bros Discovery Com Ser A (WBD)
Norfolk Southern (NSC)
Cyberark Software SHS (CYBR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Verition Fund Management

Top funds holding Anavex Life Sciences

BlackRock
Vanguard Group
State Street Corporation
Geode Capital Management
Susquehanna International
Two Sigma Investments
Nwam
Northern Trust
Two Sigma Advisers
Charles Schwab Investment Management
Citadel Advisors
Morgan Stanley
LPL Financial
UBS Group
Private Advisor

View all funds holding Anavex Life Sciences